It is possible that the inclusion of newly diagnosed and therefore uncontrolled diabetic patients together with individuals with normal glycemic control in the healthy-weight and obesity groups biased the evaluation of oxytocin levels by BMI status. Here, OXT is linked to obesity due to melanocortin 4 receptor deficiency.